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Abstract—The purpose of this study was to optimize effec-
tive, but technically challenging 99mTc-sestamibi/123I subtrac-
tion SPECT/CT protocol for parathyroid scintigraphy. An 
anthropomorphic parathyroid phantom was set up using a 
small sphere, a thyroid phantom and a thorax phantom with 
clinical range of activities of 123I and 99mTc. SPECT/CT acqui-
sitions were performed using three collimators (Low Energy 
High Resolution (LEHR), Low Energy Ultra High Resolution 
(LEUHR) and Medium Energy Low Penetration (MELP)) and 
two energy window settings. Images were reconstructed with a 
combination of four different numbers of iterations and with 
or without scatter correction. Images were subjected to visual 
and quantitative evaluation. The effect of collimator, energy 
window selection and reconstruction parameters had a signifi-
cant effect on visual appearance and adenoma contrast in 
parathyroid 99mTc-sestamibi/123I subtraction SPECT/CT. 
Symmetrical energy windows and ultra-high resolution colli-
mator yielded best results with some improvement with scatter 
correction. 
Keywords— parathyroid, SPECT/CT, phantom, optimiza-
tion, dual-isotope. 
I. INTRODUCTION  
The diagnosis of hyperparathyroidism is based on labora-
tory findings, with ionized calcium and parathormone levels 
being elevated. Patient should be referred for parathyroid 
scintigraphy only when above-mentioned diagnostic criteria 
are met. Parathyroid scintigraphy is thus not a diagnostic 
study, but a localization one. Localization of hyperfunction-
ing parathyroid glands before surgery is highly recommend-
ed to define surgical strategy. 
The only tracer available for parathyroid scintigraphy, 
99m
Tc-sestamibi is not parathyroid-specific but taken up also 
by adjacent thyroid tissue. This problem can be solved by 
using either a single isotope (dual-phase) or a dual-isotope 
method. 
The dual-phase method assumes that thyroid and para-
thyroid tissue have different washout kinetics for 
99m
Tc-
sestamibi. By acquiring images immediately after the injec-
tion and 2-3 hours later, the focally increasing uptake will 
reveal hyperfunctioning parathyroid gland. In the dual-
isotope method, 
99m
Tc-sestamibi is used together with 
123
I, 
which is taken up by the thyroid gland only. Subtracting the 
123
I image from the 
99m
Tc-sestamibi image leaves only en-
larged parathyroid glands in the subtraction image. Imaging 
findings are based on a visual appearance of subtraction 
image, confirmed with anatomical reference in the CT im-
age. 





I for parathyroid scintigraphy have been 
acknowledged in several studies and are recommended in 
the European Association of Nuclear Medicine (EANM) 
guideline for parathyroid scintigraphy [1]. This method has 
been applied in Finland, as all nuclear medicine depart-
ments performing parathyroid scintigraphy are now using 




I as their 
first method of choice in parathyroid scintigraphy [2]. 
Both planar and tomographic acquisition techniques are 
used clinically. Planar pinhole acquisition has its advantages 
due to superior spatial resolution, but modern SPECT/CT 
imaging offers three-dimensional images together with 
exact anatomical information. These techniques are often 
combined to increase sensitivity and specificity [3-4]. How-
ever, acquisition of an additional image requires the change 
of the collimator and increases the total length of the study. 
Thus, it would be attempting to simplify imaging protocol 
but this has to be done without decreasing image quality. It 
should be noted that a large, active parathyroid adenoma is 
clearly visible regardless of the imaging protocol used. The 
current clinical problem are patients with secondary hy-
perparathyroidism with relatively inactive hyperplastic 
glands, and patients with multiglandular disease, where 




I subtraction SPECT/CT is technically 
challenging. Close proximity of the photon energies 
(140keV and 158keV) with limited energy resolution of a 
gamma camera detector leads to cross-contamination of 
isotopes. Asymmetric energy window for 
123
I is generally 
used to reduce 
99m
Tc contamination in 
123
I energy window, 
[6-7].  The septal penetration of high-energy photons of 
123
I 
is also a potential cause of artefacts in subtraction images. 
The selection of collimator (due to different septal thick-
2 
ness, resolution and sensitivity) has thus a marked effect on 
the final results [8]. Reconstruction parameters and the use 
of scatter correction will also have effect [9-10]. 






SPECT/CT - protocol using an anthropomorphic phantom. 
The effect of collimator choice, energy window settings and 
the reconstruction parameters (number of iterations, scatter 
correction) were studied. 
II. MATERIALS AND METHODS 
For the purpose of this study, a phantom mimicking para-
thyroid patient with a small, low intensity adenoma was set 
up (Figure 1). A thyroid gland phantom (Radiology Support 




Tc (concentration of 
500 kBq/ml). A small sphere with inner diameter of 
7.86mm (Micro Hollow Sphere, Data Spectrum) was filled 
with lower 
99m
Tc –concentration as thyroid gland 
(~300kBq/ml) to mimic small parathyroid adenoma or hy-
perplastic gland (0.25ml with ~125kBq of 
99m
Tc) and at-
tached behind the thyroid gland. The thyroid and parathy-
roids were inserted into the thorax phantom (Radiology 
Support Devices), which was then filled with 350MBq of 
99m
Tc. Activities were measured using a VIK-202 ionization 
chamber (Veenstra) used in clinical work and subjected to 
strict daily quality control measures. 
A series of SPECT/CT scans were performed with three 
sets of collimators: Low Energy High Resolution (LEHR), 
Low Energy Ultra High Resolution (LEUHR) and Medium 
Energy Low Penetration (MELP) and with two energy win-
dow settings, clinical and test windows (Table I).  
SPECT was acquired using normal clinical acquisition 
protocol (a noncircular orbit, 180 detector configuration, 
128128 matrix; 4.8 mm pixel size; step-and-shoot, 48 
views for each detector, 33 s/projection). 
 
Figure 1. Thorax phantom, the thyroid gland and spherical phantom mim-
icking parathyroid adenoma. Images are not in scale. 
 















Scatter - 15% 112 – 133 
99mTc 140 keV 10% 133 – 147 
Scatter - 7% 147 – 156 
123I 167 keV 10% 159 – 175 
     
Test  
Scatter - 15% 112 – 133 
99mTc 140 keV 10% 133 – 147 
Scatter - 2% 147 – 149 
123I 158 keV 10% 150 – 165 
 
The CT acquisition for attenuation correction and image 
fusion was acquired after the SPECT acquisition without 
moving the phantom and using the same scan area as for 
SPECT (130 kVp, 22.5 mm collimation, 0.8 s rotation 
time, 1.5 pitch, CARE Dose AEC+DOM, with the ref. ex-
posure 80 mAs). All acquisitions were performed with Sie-
mens Symbia Intevo T2 SPECT/CT ((Siemens, Erlangen, 






I SPECT images (with attenuation 
correction) were reconstructed on the Siemens Syngo work-
station using the FLASH 3D-algorithm with eight parameter 
settings (6, 8, 16 or 32 iterations, 8 subsets, Gaussian 9.00 
filter, with and without TEW scatter correction). 
123
I SPECT images were multiplied by a normalization 




I SPECT images to create normalized 
123
I 
SPECT images, which were then subtracted from 
99m
Tc 
SPECT images. All images were subjected to visual and 
quantitative evaluation. Image processing and evaluation 
was performed by an experienced medical physicist. All 
images were anonymized (no knowledge of collimator or 
acquisition or processing parameters) and scored from 0 to 
5. Scoring was based on clinical appearance (the intensity of 
adenoma, the presence of artefacts). 
For quantitative analysis, a VOI was drawn around the 
sphere using the fused CT image as a reference (with corre-
sponding background VOI). An image contrast C for sphere 









C   [1] 
where: 
Cadenoma is the number of counts in the sphere, 
Cbackground is the number of counts in the background area 
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The mean values for contrast and visual scores were cal-
culated for each collimator (all energy windows and pro-
cessing parameters), for each energy window setting (all 
collimators and processing parameters) and for scatter cor-
rection (all collimators, energy windows and processing 
parameters). 
III. RESULTS 
The calculated contrast for adenoma was between 0,4%-
80,9%. The visual scores were between 0-5. The contrast 
and visual scores were in correlation (Figure 2). The mean 
values for contrast and visual scores were highest for 
LEUHR collimator and for test energy windows settings. 
Contrast values were higher with scatter correction, but 
visual scores were lower (Table 2). 
 
 
Figure 2. Visual score as a function of contrast. 
Table 2 Mean contrast values and visual scores calculated for collimators, 
energy window settings and with or without scatter correction 
 
Contrastmean Visualmean 
MELP 18 % 0,9 
LEHR 26 % 1,8 
LEUHR 47 % 2,9 
   
Clinical 18 % 0,8 
Test 43 % 2,9 
   
SC- 28 % 1,9 
SC+ 32 % 1,8 
 
The mean values for contrast for reconstruction parame-
ters (for all collimators and energy window settings) were 
higher with an increasing number of iterations. However, 
visual scores were highest with 16 iterations, increasing 
iterations to 32 decreased the visual appearance of the im-
ages (Table 3). 
Table 3 Mean contrast values and visual scores calculated for eight 
reconstruction parameter settings for all collimators 
Iteration, SC-/SC+ Contrastmean Visualmean 
6, SC- 24 % 1, 7 
8, SC- 26 % 1,7 
16, SC- 30 % 2,2 
32, SC- 33 % 2,0 
6, SC+ 22 % 1,5 
8, SC+ 27 % 1,7 
16, SC+ 36 % 2,2 
32, SC+ 47 % 2,0 
 
 
The mean values for contrast for each combination of 
collimator, energy window and scatter correction are pre-
sented in Table 4. The highest mean values for contrast and 
visual scores were with LEUHR collimator with not-
corrected test energy window. Phantom images with highest 
visual scores and with current clinical protocol are present-
ed in Figure 3. 
Table 4 Mean contrast values and visual scores calculated for collimators 
with two energy window settings and with or without scatter correction 
Collimator, Energy Window, 
Correction 
Contrastmean Visualmean 
MELP, Clinical, SC+ 2 % 0,0 
MELP, Clinical, SC- 9 % 0,0 
MELP, Test, SC- 25 % 1,5 
MELP, Test, SC+ 37 % 2,3 
   
LEHR, Clinical, SC- 9 % 0,5 
LEHR, Clinical, SC+ 9 % 0,5 
LEHR, Test, SC- 30% 2,5 
LEHR, Test, SC+ 55 % 3,5 
   
LEUHR, Clinical, SC- 30 % 2,0 
LEUHR, Clinical, SC+ 50 % 2,0 
LEUHR, Test, SC- 67 % 4,8 






Figure 3. From left to right, transverse, sagittal, and coronal images of the 
phantom  (an adenoma is located at the crosshair).  A) LEHR Clinical, 8 
iterations, no scatter correction (current clinical protocol), B) LEHR Test, 
16 iterations, scatter correction, and C) LEUHR Test, 16 iterations, no 
scatter correction. The red arrow is showing “the edge artefact”. 
IV. DISCUSSION 
The findings of this study confirmed that the selection of 
collimator, energy window positioning and reconstruction 
parameters have a significant effect on the visual appear-
ance of images. Collimators with higher resolution yielded 
better results, as did increasing iterations in reconstruction. 
The energy window setting had a significant effect on the 
appearance of subtraction images, as symmetric window for 
123
I was always better than asymmetric window. Scatter 
correction increased calculated contrast, but at the same 
time, the visual appearance was decreased due to increased 
noise. 
Current clinical protocol for parathyroid scintigraphy 
with LEHR collimator, asymmetric energy window without 
scatter correction was able to visualize adenoma only faint-
ly. Switching to symmetric energy window for 
123
I and 
applying scatter correction with more iterations was able to 
increase visual score from 0,5 to 3,5. MELP collimator 
would be attempting choice for imaging with 
123
I due to 
thicker septa, but low spatial resolution is not adequate 
when searching for small, relatively inactive parathyroid 
gland. LEUHR collimator with symmetric energy windows 
had best contrast and visual scores. The scatter correction in 
fact decreased these results, probably due to statistics as 
LEUHR collimator has sensitivity of approximately 50% 
compared to LEHR collimator and subtraction-based scatter 
correction reduces counts even further. The visual effect of 
increasing noise is visible in the Figure 3, where the artifac-
tual “blobs” have a similar appearance to parathyroid ade-
noma. However, this misinterpretation can be avoided with 
the use of CT, and the search of the anatomical reference. 
The so-called edge artefact [11] is currently the main 





traction SPECT/CT (Figure 3). According to the results of 
this study, the edge-artefact is more present with lower 
resolution image and with asymmetric 
123
I window. LEUHR 
symmetric window images did not include any marked 
artefact. 
According to the results of this study, increasing the 
number of iterations to more than 16 decreased the visual 
scores due to increased noise. However, it should be noted 
that this is highly dependent on camera and collimator spec-






Due to large variation of adenoma contrast and visual 
scores in this study, we find that the protocols used in clini-
cal practice should be thoroughly tested using phantoms. 
Although clinical situation is different when comparing to 
phantom studies (patient movement, breathing, extra thyroid 
99m
Tc-sestamibi activity), the ultimate detection limit should 
be resolved. 
V. CONCLUSIONS  
The effect of collimator, energy window selection and 
reconstruction parameters have a significant effect on visual 





I subtraction SPECT/CT. Symmetrical energy 
windows and high-resolution collimator yielded best results 
with some improvement with scatter correction. 
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